The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors

Ähnliche Einträge

• The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors
  von: Lepper, Alisa
  Veröffentlicht: (2025)
• Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs: original research
  von: Lepper, Alisa, et al.
  Veröffentlicht: (2023)
• Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
  von: Koch, Elias A. T., et al.
  Veröffentlicht: (2024)
• Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients
  von: Machiraju, Devayani, et al.
  Veröffentlicht: (2021)
• Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events
  von: Gente, Karolina, et al.
  Veröffentlicht: (2023)